Prot# SG030-0004: A Phase II Multi-Dose Study of SGN-30 (anti-CD30 mAb) in Patients with Primary Cutaneous Anaplastic Large Cell Lymphoma, Large Cell Transformation of Mycosis Fungoides and Lymphomatoid Papulosis

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/31/0612/1/11

Funding

  • Seattle Genetics, Inc. (SG030-0004)